Antitoxin and vaccine platform based on nodavirus VLPs
US7998487B2 · kind B2 · utility
2Cited by
2References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 14, 2008 |
| Grant date | Aug 16, 2011 |
| Priority date | — |
| Expiry date | Feb 14, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/30023
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antitoxin and vaccine compositions based on nodavirus VLPs are provided. Anthrax antitoxin and vaccine compositions are provided. Methods of treating toxins with VLP-based antitoxins are provided. Methods of raising an immune response with immunogen decorated VLPs are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.